Literature DB >> 6374837

Selective primary health care: strategies for control of disease in the developing world. XI. Dengue.

S B Halstead.   

Abstract

Since World War II, dengue viruses have progressively extended their geographic domain and have increased as causes of human morbidity and mortality. This complex of four flaviviruses is principally transmitted to humans by the bite of Aedes aegypti, the yellow fever vector. Factors that promote the indoor storage of water are congenial to the breeding of A. aegypti. These include the dislocations of wars, overpopulation , and urbanization. By the mid-20th century, A. aegypti eradication campaigns had nearly succeeded in much of the Western Hemisphere. Since then, there has been a steady degradation in ability to cope with this species despite the fact that a newly emerged, severe immunopathologic disorder, dengue hemorrhagic fever/dengue shock syndrome, endows dengue epidemics with grave consequences. Development of a vaccine against dengue is complicated by the need to develop four different live attenuated vaccines and by a justifiable caution imposed by dengue immunopathology. A wide range of proven methods have been and are available to reduce populations of A. aegypti. This paper argues that the eradication strategy adopted earlier in this century is still viable and cost effective. Critical to a successful control program is a prioritied approach, a thorough, disciplined planning effort, a commitment to assessment, adequate compensation of staff, and, above all, the will to succeed.

Entities:  

Mesh:

Year:  1984        PMID: 6374837     DOI: 10.1093/clinids/6.2.251

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  9 in total

1.  Comparison of two rapid diagnostic assays for detection of immunoglobulin M antibodies to dengue virus.

Authors:  S J Wu; H Paxton; B Hanson; C G Kung; T B Chen; C Rossi; D W Vaughn; G S Murphy; C G Hayes
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

2.  Evaluation of a dipstick enzyme-linked immunosorbent assay for detection of antibodies to dengue virus.

Authors:  S J Wu; B Hanson; H Paxton; A Nisalak; D W Vaughn; C Rossi; E A Henchal; K R Porter; D M Watts; C G Hayes
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

3.  Clinical evaluation of a rapid immunochromatographic test for the diagnosis of dengue virus infection.

Authors:  C T Sang; L S Hoon; A Cuzzubbo; P Devine
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

4.  Dengue haemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981.

Authors:  G P Kouri; M G Guzmán; J R Bravo; C Triana
Journal:  Bull World Health Organ       Date:  1989       Impact factor: 9.408

5.  VACCINES - WHAT'S NEW?

Authors:  C G Wilson; P L Prasad; K Nagendra
Journal:  Med J Armed Forces India       Date:  2011-07-21

6.  An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells.

Authors:  Jan-Jong Hung; Meng-Ti Hsieh; Ming-Jer Young; Chuan-Liang Kao; Chwan-Chuen King; Wen Chang
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

Review 7.  Dengue: the risk to developed and developing countries.

Authors:  T P Monath
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

8.  Development of ASSURE Dengue IgA Rapid Test for the Detection of Anti-dengue IgA from Dengue Infected Patients.

Authors:  Yun Ying Tan; Shamala D Sekaran; Seok Mui Wang; Firoz Ahmed; Anowar Hossain; Bijon Kumar Sil
Journal:  J Glob Infect Dis       Date:  2011-07

9.  Quantifying the localized relationship between vector containment activities and dengue incidence in a real-world setting: A spatial and time series modelling analysis based on geo-located data from Pakistan.

Authors:  Nabeel Abdur Rehman; Henrik Salje; Moritz U G Kraemer; Lakshminarayanan Subramanian; Umar Saif; Rumi Chunara
Journal:  PLoS Negl Trop Dis       Date:  2020-05-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.